Ctsb Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
.infobox .infobox-gene
| Gene Symbol | CTSB |
|---|---|
| Gene Name | Cathepsin B |
| Chromosome | 8p23.1 |
| NCBI Gene ID | 1508 |
| OMIM ID | 116810 |
| Ensembl ID | ENSG00000164733 |
| UniProt ID | P07846 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Cancer, Lysosomal Storage Disorders |
| --- | --- |
| Categories | Lysosomal Pathway, Proteases |
Cathepsin B (CTSB) is a cysteine protease localized primarily to lysosomes where it functions in protein degradation and turnover. As a member of the cathepsin family, CTSB has both endopeptidase and exopeptidase (carboxydipeptidase) activity, allowing it to cleave proteins at internal sites and remove dipeptides from the C-terminus. The enzyme is synthesized as an inactive preproenzyme and undergoes proteolytic processing to generate the mature, active form. CTSB participates in various physiological processes including extracellular matrix remodeling, antigen processing, and apoptosis. In the brain, CTSB is expressed in neurons and glia and contributes to amyloid-beta degradation under normal conditions. However, in Alzheimer's disease, CTSB activity can be detrimental as it may generate amyloid-beta fragments that are more aggregation-prone and may promote tau pathology. In Parkinson's disease, CTSB may contribute to alpha-synuclein degradation but also to dopaminergic neuron death through lysosomal membrane permeabilization.
Cathepsin B is a lysosomal cysteine protease involved in protein degradation within lysosomes. It plays important roles in cellular protein turnover, antigen processing, and extracellular matrix remodeling. In neurodegenerative diseases, cathepsin B is implicated in the cleavage of amyloid precursor protein (APP) and may contribute to amyloid-beta generation. Its activity is elevated in Alzheimer's disease brains, and inhibitors of cathepsin B are being explored as therapeutic candidates.
The CTSB gene is associated with several diseases.
The study of Ctsb Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.